378 related articles for article (PubMed ID: 35370869)
1. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma.
Ren W; Jin W; Liang Z
Front Neurol; 2022; 13():832944. PubMed ID: 35370869
[TBL] [Abstract][Full Text] [Related]
2. Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Hu L; Han Z; Cheng X; Wang S; Feng Y; Lin Z
Front Genet; 2021; 12():638458. PubMed ID: 33708242
[TBL] [Abstract][Full Text] [Related]
3. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
4. Development of a prognostic model of glioma based on immune-related genes.
Wang JJ; Wang H; Zhu BL; Wang X; Qian YH; Xie L; Wang WJ; Zhu J; Chen XY; Wang JM; Ding ZL
Oncol Lett; 2021 Feb; 21(2):116. PubMed ID: 33376548
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
Front Oncol; 2020; 10():1588. PubMed ID: 33014809
[TBL] [Abstract][Full Text] [Related]
6. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
7. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a robust prognostic model based on immune features in sepsis.
Zheng Y; Liu B; Deng X; Chen Y; Huang Y; Zhang Y; Xu Y; Sang L; Liu X; Li Y
Front Immunol; 2022; 13():994295. PubMed ID: 36532037
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes.
Peng Z; Liu XY; Cheng Z; Kai W; Song Z
Ann Transl Med; 2021 Oct; 9(20):1576. PubMed ID: 34790782
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma.
Zhu W; Luo N; Li Q; Chen X; Li X; Fu M; Yang F; Chen Z; Zhang Y; Zhang Y; Peng X; Hu G
Ann Transl Med; 2023 Jan; 11(2):69. PubMed ID: 36819551
[TBL] [Abstract][Full Text] [Related]
11. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
12. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
13. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
14. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
[TBL] [Abstract][Full Text] [Related]
15. A Prognostic Microenvironment-Related Immune Signature
Qiu H; Li Y; Cheng S; Li J; He C; Li J
Front Oncol; 2020; 10():580263. PubMed ID: 33425732
[TBL] [Abstract][Full Text] [Related]
16. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
[TBL] [Abstract][Full Text] [Related]
17. Development of an Immune-Related Prognostic Index Associated With Glioblastoma.
Jiang Z; Shi Y; Zhao W; Zhang Y; Xie Y; Zhang B; Tan G; Wang Z
Front Neurol; 2021; 12():610797. PubMed ID: 34093386
[No Abstract] [Full Text] [Related]
18. Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma.
Wang WJ; Wang H; Hua TY; Song W; Zhu J; Wang JJ; Huang YQ; Ding ZL
Front Genet; 2020; 11():55. PubMed ID: 32158466
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
Jin Y; Deng J; Luo B; Zhong Y; Yu S
Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
[TBL] [Abstract][Full Text] [Related]
20. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
